Condition
Hypersalivation
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Unknown2
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT04132765UnknownPrimary
Turkish Validation of The Drooling Impact Scale
NCT02102542CompletedPrimary
Efficacy of Intravenous Glyco-P® in Patients Undergoing Procedure That Require Anesthesia Service
NCT01045720Phase 2Unknown
The Treatment of 2 Chinese Medicines in Clozapine-induced Hypersalivation in Schizophrenia
NCT00381589Not ApplicableCompletedPrimary
Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide
Showing all 4 trials